USPTO serial 86271626
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2016
- Examiner
- MALASHEVICH, JASON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $3,400
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen K. Won
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Publications, namely, printed materials, brochures, pamphlets, bulletins, newsletter and magazines in the field of cancer, bioinformatics and biotechnologies | ACTIVE | — |
| 041 | Medical educational and training services, namely, conducting lectures, seminars, workshops, conferences, internships, fellowships, residencies, and workshops in the field of cancer | ACTIVE | — |
| 042 | Medical, clinical, and scientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; Scientific and technological services, namely, collaborative scientific research and development services for researchers in the fields of oncology, namely, development of proprietary bioinformatic analysis software pipelines and computer systems for collecting, storing, characterizing, sorting, viewing, and delivering medical data and research information to clients; designing genomic experiments in context of client driven strategic goals; providing scientific research data, including custom, proprietary bioinformatic analysis of data generated in the fields of genomics and oncology; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples; Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific and technological services, namely, research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of bioinformatics and oncology; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online nondownloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting clinical studies and selecting patients for clinical studies in the field of cancer therapy for others; Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technological and scientific data analysis in the field of oncology; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; providing temporary use of non-downloadable scientific research and analysis software in the field of oncology and bioinformatics; Providing a website portal featuring bioinformatic research data and search engine for biomedical data for data mining and pattern recognition, selecting patients for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; providing temporary use of non-downloadable bioinformatic software for diagnosing medical conditions, preparing medical data, research and reports for data mining and pattern recognition, selecting patient for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; technical and scientific data analysis in the field of oncology | ACTIVE | — |
| 044 | Data collection for research purposes, namely, providing medical evaluations of patients to determine acceptability for participation in clinical trials; Providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of cancer; Healthcare services, namely, providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by M2GEN, CORP.
- Other trademarks owned by Moffitt Genetics Corporation
- Other trademarks owned by Moffitt Genetics Corporation
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Dec 11, 2025 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 11, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Dec 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 11, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 11, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 29, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| May 24, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 10, 2022 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Nov 10, 2022 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Nov 8, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| May 25, 2022 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| May 25, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 10, 2022 | ES8R | TEAS SECTION 8 RECEIVED | — |
| May 24, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 29, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 24, 2016 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Apr 15, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 8, 2016 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Apr 8, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 8, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 29, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 29, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 18, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 5, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2015 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Sep 15, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2015 | IUAA | USE AMENDMENT ACCEPTED | — |
| Sep 11, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2015 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Sep 11, 2015 | IUAF | USE AMENDMENT FILED | — |
| Sep 10, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 10, 2015 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Mar 11, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 22, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 22, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2014 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 5, 2014 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 8, 2014 | NWAP | NEW APPLICATION ENTERED | — |